Drugs

Activities Report of the Generic Drug Program (FY 2017)

GDUFA YEAR/Actions This Month16-Oct16-Nov16-Dec17-Jan17-Feb17-Mar17-Apr17-May17-Jun17-Jul17-Aug17-SepFY-2017
Refuse to Receive (RTR) + 9 824 *        41
Withdrawals (all original ANDAs) 9 611 *        26
Approvals + 54 59 56 51        220
Tentative Approvals + 16 12 19 14        61
Complete Responses (CR) + 151 150 144 144        589
Drug Master File Completeness Assessment (DMF CA) 52 5081 *        183
GDUFA YEAR (Receipts)Submissions This Month16-Oct16-Nov16-Dec17-Jan17-Feb17-Mar17-Apr17-May17-Jun17-Jul17-Aug17-SepFY-2017
Abbreviated New Drug Applications (ANDA) ++108 81 235 57        481
CBE Supplements493 430530 *        1453
PAS Supplements43 2738 *        108
GDUFA YEAR (Receipts)Submissions This Month16-Oct16-Nov16-Dec17-Jan17-Feb17-Mar17-Apr17-May17-Jun17-Jul17-Aug17-SepFY-2017
Controls +++153 162 134 *        449
GDUFA Post CR Meeting Requests ++++178 180 181 *         
Post CR Meeting Requests this month2 2 1 *        5

NOTE: Numbers reflect current data at the time of posting and may change based on refreshed counts in our tracking systems, including application status updates.
These numbers are not intended for Congressional reporting purposes.

* = This data requires additional verification and will be posted when available.
+ = Revised to reflect more accurate counting by our tracking systems. For example, RTRs revised to include both RTR due to failure to pay user fees and RTR due to technical reasons.
++ = Starting FY15, ANDA Original Receipts are reported as raw receipts (versus filed receipts).
+++ = Controls have been revised to count only those requests deemed appropriate for a control.
++++ = Cumulative and NOT specific to the month.

Page Last Updated: 02/07/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English